Profil
Robert Taggart worked as a Principal at American Fronteer Financial Corp.
and as a Vice President-National Sales at Bacterin International Holdings, Inc. from 2011 to 2012.
Ehemalige bekannte Positionen von Robert Taggart
Unternehmen | Position | Ende |
---|---|---|
Bacterin International Holdings, Inc.
Bacterin International Holdings, Inc. Medical SpecialtiesHealth Technology Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Its bone graft products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The company's acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. It also develops custom surgical instruments for use with its allografts, and it produces and distributes OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. The company was founded by Guy S. Cook in 1998 and is headquartered in Belgrade, MT. | Vertrieb & Marketing | 15.02.2012 |
American Fronteer Financial Corp. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Bacterin International Holdings, Inc.
Bacterin International Holdings, Inc. Medical SpecialtiesHealth Technology Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Its bone graft products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The company's acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. It also develops custom surgical instruments for use with its allografts, and it produces and distributes OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. The company was founded by Guy S. Cook in 1998 and is headquartered in Belgrade, MT. | Health Technology |
American Fronteer Financial Corp. | Finance |